Targeting of Topoisomerase I for Prognoses and Therapeutics of Camptothecin-Resistant Ovarian Cancer

PLoS ONE - United States
doi 10.1371/journal.pone.0132579
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Characterization of DNA Topoisomerase-1 in Spodoptera Exigua for Toxicity Evaluation of Camptothecin and Hydoxy-Camptothecin

PLoS ONE
Multidisciplinary
2013English

Increased Camptothecin Toxicity Induced in Mammalian Cells ExpressingSaccharomyces cerevisiaeDNA Topoisomerase I

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1998English

Molecular and Cytotoxic Effects of Camptothecin, a Topoisomerase I Inhibitor, on Trypanosomes and Leishmania.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1995English

Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics

International Journal of Cell Biology
Cell Biology
2015English

Targeting Tumor Suppressor Networks for Cancer Therapeutics

Current Drug Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2014English

Targeting Microenvironment in Cancer Therapeutics

Oncotarget
Oncology
2016English

Design and Optimization of Camptothecin Conjugates of Triple Helix-Forming Oligonucleotides for Sequence-Specific DNA Cleavage by Topoisomerase I

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Mitochondria-Targeting Polydopamine Nanocomposites as Chemophotothermal Therapeutics for Cancer

English

Targeting Genetic Alterations in Protein Methyltransferases for Personalized Cancer Therapeutics

Oncogene
Cancer ResearchGeneticsMolecular Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy